Champignon Brands continues to work with the BC Secutiries Commission to complete its disclosure review.
Another private player in the psychedelics industry moves to go public. Prospectus available on SEDAR.
A major IPO can be expected to attract a lot of new attention (and capital) to the psychedelic drug industry.
Novamind Ventures' new CMO has led over 100 clinical trials and currently serves as a Coordinating Investigator for MAPS.